Abstract
Long-acting, reversible contraceptives are about 20 times more effective in terms of contraceptive efficacy than oral hormonal contraceptives, patch or vaginal ring are. Long-acting, reversible contraceptives are not associated with serious adverse events but induce changes in menstrual bleeding pattern in about 75% of the users. The progestogen intrauterine device is effective in the treatment of menorhagia and dysmenorrhoea. Increased use of long-acting reversible contraceptives is expected to reduce unplanned pregnancies and legal abortions in all ages. Concomitant use of barrier methods is important to prevent sexually transmitted diseases.
Translated title of the contribution | Contraception for young women with focus on long-acting, reversible contraceptives |
---|---|
Original language | Danish |
Article number | V04170314 |
Journal | Ugeskrift for Læger |
Volume | 180 |
Issue number | 4 |
Pages (from-to) | 342-345 |
ISSN | 0041-5782 |
Publication status | Published - 1. Jan 2018 |